| Phase 2 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT06797544 | Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis | Cutaneous Leishmaniasis | Recruiting | 2025-09-30 |
| NCT06798415 | Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis | Cutaneous Leishmaniasis | Recruiting | 2025-02-14 |